1-6 of 6
Christopher A. Klebanoff
Close
Sort by
Journal Articles

Generation of clinical-grade CD19-specific CAR-modified CD8 + memory stem cells for the treatment of human B-cell malignancies

Marianna Sabatino, Jinhui Hu, Michele Sommariva, Sanjivan Gautam, Vicki Fellowes, James D. Hocker, Sean Dougherty, Haiying Qin, Christopher A. Klebanoff, Terry J. Fry, Ronald E. Gress, James N. Kochenderfer, David F. Stroncek, Yun Ji, Luca Gattinoni
Journal: Blood
Blood (2016) 128 (4): 519–528.
https://doi.org/10.1182/blood-2015-11-683847
Published: 2016
Includes: Supplemental data
Journal Articles

Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration

Kazutoshi Aoyama, Asim Saha, Jakub Tolar, Megan J. Riddle, Rachelle G. Veenstra, Patricia A. Taylor, Rune Blomhoff, Angela Panoskaltsis-Mortari, Christopher A. Klebanoff, Gérard Socié, David H. Munn, William J. Murphy, Jonathan S. Serody, LeShara M. Fulton, Takanori Teshima, Roshantha A. Chandraratna, Ethan Dmitrovsky, Yanxia Guo, Randolph J. Noelle, Bruce R. Blazar
Journal: Blood
Blood (2013) 122 (12): 2125–2134.
https://doi.org/10.1182/blood-2012-11-470252
Published: 2013
Includes: Supplemental data
Journal Articles

Stubborn Tregs limit T-cell therapy

Christopher A. Klebanoff, Luca Gattinoni
Journal: Blood
Blood (2012) 120 (12): 2352–2354.
https://doi.org/10.1182/blood-2012-08-445239
Published: 2012
Journal Articles

Human effector CD8 + T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy

Christian S. Hinrichs, Zachary A. Borman, Luca Gattinoni, Zhiya Yu, William R. Burns, Jianping Huang, Christopher A. Klebanoff, Laura A. Johnson, Sid P. Kerkar, Shicheng Yang, Pawel Muranski, Douglas C. Palmer, Christopher D. Scott, Richard A. Morgan, Paul F. Robbins, Steven A. Rosenberg, Nicholas P. Restifo
Journal: Blood
Blood (2011) 117 (3): 808–814.
https://doi.org/10.1182/blood-2010-05-286286
Published: 2011
Includes: Supplemental data
Journal Articles

Programming tumor-reactive effector memory CD8 + T cells in vitro obviates the requirement for in vivo vaccination

Christopher A. Klebanoff, Zhiya Yu, Leroy N. Hwang, Douglas C. Palmer, Luca Gattinoni, Nicholas P. Restifo
Journal: Blood
Blood (2009) 114 (9): 1776–1783.
https://doi.org/10.1182/blood-2008-12-192419
Published: 2009
Includes: Supplemental data
Journal Articles

IL-2 and IL-21 confer opposing differentiation programs to CD8 + T cells for adoptive immunotherapy

Christian S. Hinrichs, Rosanne Spolski, Chrystal M. Paulos, Luca Gattinoni, Keith W. Kerstann, Douglas C. Palmer, Christopher A. Klebanoff, Steven A. Rosenberg, Warren J. Leonard, Nicholas P. Restifo
Journal: Blood
Blood (2008) 111 (11): 5326–5333.
https://doi.org/10.1182/blood-2007-09-113050
Published: 2008
Includes: Supplemental data